In: Anatomy and Physiology
Complete the following table to demonstrate comparison of pathophysiology, platelet findings, and clinical symptoms associated with platelet disorders
Platelet Disorder |
Pathophysiology |
Platelet Findings |
Patient Symptoms |
Drug‐induced
thrombocytopenia [quinines, NSAIDs, heparin, |
|||
Idiopathic thrombocytopenic |
|||
Thrombotic thrombocytopenic |
|||
Hemolytic uremic syndrome |
|||
Essential thrombocytosis |
|||
Von Willebrand disease |
|||
Bernard‐Soulier syndrome |
|||
Glanzmann’s thrombasthenia |
|||
Aspirin |
Disorder | pathophysiology | platelet findings | patient symptoms |
Drug-induced thrombocytopenia (quinines, NSAIDS, heparin, sulfonamides, amoxicillin. diuretics) |
Quinines, sulfonamides, NSAIDs: Mechanism: drug dependent antibody Description: Drug interacts noncovalently with platelet membrane glycoprotein, antibody binds to drug-glycoprotein complex Penicillin derivatives: Mechanism: Hapten dependent Description: drug forms covalent linkage with membrane glycoprotein, to act as a hapten to induce Drug dependent antibody(DDA) response Heparin: Mechanism: Immune complex Description: drug reacts with platelet factor 4 and produces an antigenic complex. Antibodies react against the antigenic complex to form immune complexes, that binds to platelet fc receptor, resulting in platelet activation. |
Moderate : <50000 / L Severe: <10000/L |
petechiae (red spots on the skin), abnormal vaginal/ rectal/ oral/ nasal bleeding, gastrointestinal bleeding, excessive bruising over minor fall, headache(in severe cases) |
Idiopathic thrombocytopenic purpura | due to autoantibody- mediated destruction of macrophages in spleen, and moderaately impaired platelet production due to antibody and/ or cytotoxic T-cell mediated megakaryocytic damage, the platelet mass shrinks as a result of accelerate platelet clearance. |
Moderate: <100000 severe: <10000 |
Purpura(purple spots under the skin), petechiae, excessive bleeding during surgery, abnormal oral/nasal/rectal/vaginal bleeding, blood in urine or stool |
Thrombotic thrombocytopenic purpura |
involves nonimmunologic platelet destrcution. loose strands of platelets and fibrin are deposited in multiple vessels and damage passing platelets and RBCs, causing thrombocytopenia. consumption of platelet within multiple small thrombi also contribute to thrombcytopenia. Antibodies inhibit the enzyme ADAMTS13 (von willebrand cleaving protease, a protein involved in blood clotting) which results in decrease of breakdown of large multimers of von willebrand factor |
<30 x109 /L | Purpura, petechiae, jaundice, fatigue, fever, low urine output, headache, seizure, stroke, confusion, speech changes, shortness of breath |
Hemolytic uremic syndrome | Shiga toxins (STx1, STx2) are released by E.coli in the intestine > absorption of the toxin by the epithelium of the gastrointestinall system> reaches target organ > binds to globotriosylceramide (Gb3, a glycopeptide surface receptor in the epithelium of the target organ)> inhibits protein synthesis>endothelial damage> cell death, inflammatory response, thrombocyte activation |
<150000/mm3 |
bloody diarrhea, abdominal pain, cramping, vomiting, pale skin, fever, fatigue, abdominal swelling, confusion, decreased urine output |
Essential thrombocytosis |
a point mutation chnging aminoacid valine to phenylalanine at codon 617 of the JAK2 gene causing myeloproliferative neoplasms presence of megakaryocytic hyperplasia in the bone marrow |
>450000 / microL | headache, dizziness, chest pain, numbness, throbbing/ burning pain, redness hands and feet, vision changes, abnormal vaginal/ rectal/ oral/ nasal bleeding, bloody stool |
Von Willebrand disease | defect in the van willebrand factor. | normal |
abnormal vaginal/ rectal/ oral/ nasal bleeding excessive bleeding during childbirth, excessive bruising over minor fall |
Bernard-Soulier syndrome |
mutation in: GPI b GPI b GPIX |
thrombocytopenia | nosebleeds, heavy menstrual flow, excessive bleeding |
Glanzmann's thrombasthenia | |||
Aspirin |